Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo‐controlled trial

Abstract

Addition of nateglinide before meals to once-daily insulin glargine in people with long-standing diabetes already requiring insulin therapy improves blood glucose control in the early part of the day after breakfast and lunch, but does not provide good control of blood glucose levels overall.